The use of cell fusion to analyse factors involved in tumour cell metastasis

International Journal of Cancer

Volumn 32, Issue 4, 1983, Pages 471-478

  Ramshaw, I A ^a   Carlsen, S ^b   Wang, H C ^b   Badenoch Jones P ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR;

BREAST; BREAST CANCER; CANCER CELL; CELL FUSION; IN VITRO STUDY; METASTASIS; NONHUMAN; RAT;

ADENOCARCINOMA; ANIMAL; CELL FUSION; FEMALE; HYBRID CELLS; KARYOTYPING; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PHENOTYPE; PLASMINOGEN ACTIVATORS; RATS; RATS, INBRED F344; SUPPORT, NON-U.S. GOV'T;

EID: 0020621782     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910320414     Document Type: Article

References (16)

1. 3H‐labelled fibrinogen prepared by reductive alkylation
2. Ovarian plasminogen activator: relationship to ovulation and hormonal regulation
3. The suppression of tumorigenicity in human X mouse cell hybrids. 1. Derivation of hybrid clones, chromosome analysis and tumorigenicity studies
4. Cancer genes in cell hybrids
5. Inhibition of tissue‐type plasminogen activator by conditioned medium for cultured human and procine vascular endothelial cells
6. A study of proteases and protease‐inhibitor complexes in biological fluids
7. Implications of tumor heterogeneity for studies on the biology and therapy of cancer metastasis
8. The production of fibrinolysis inhibitors as a parameter of the activation state in murine macrophages
9. Expression of transformation markers and suppression of tumorigenicity in human cell hybrids
10. Selection of hybrids from mating of fibroblasts In vitro and their presumed recombinants
11. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non‐malignant subclone: realtionships between plasminogen activator expression by the tumor cells and the host's immune response
12. A 6‐thioguanine‐resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic
13. Cloning
14. Human cell hybrids: analysis of transformation and tumorigenicity
15. Growth In vitro of tumor cell X fibroblast hybrids in which malignancy is suppressed
16. Correlation of the production of plasmingen activator with tumor metastasis in B16 mouse melanoma cell lines